Meta Pixel

News and Announcements

7 Questions Thematic Investors Want To Know About The Current Market

  • Published December 14, 2022 8:24AM UTC
  • Publisher Osama Hassan
  • Categories Capital Raising Tips

​​​​Over the last few months, Steve Torso and the team at Wholesale Investor have been fielding questions from investors. At WI, we’ve identified 7 key thematic investors want to know more about in current market conditions: 

1) What are the yield opportunities available across listed markets, private debt, and alternative investments?

2) What are the keys to venture investing during a bear market or a recession, and the path to compound returns?

3) How do you profit from the volatility of the public markets and small caps?

4) What are the long-term mega-trends, current stages of adoption and exponential growth opportunities being created, which aren’t impacted by a bear market or recession?

5) Web 3.0 generated a lot of interest and hype in 2021, what comes next for this space? What will be the market opportunities over the next 3 to 5 years?

6) How do you navigate your investment approach for the crypto winter and the next bitcoin halving cycle?

7) Is this the bottom? Where to from here?

Venture and Capital Conference is our destination to answer these kind of questions.

3 days, 60+ Speakers and panellists, and over 90 opportunities to assist you in answering these questions, forming your own thesis and taking advantage of what has been described as a once-in-a-generation market opportunity.

Join us from July 25th to 27th at Venture and Capital in Sydney. 

Click here to view the original Linkedin post.

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now